These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3027797)

  • 1. [Study of the hepatitis B virus-neutralizing response in acute infection and in patients vaccinated against the infection].
    Pontisso P; Schiavon E; Stenico D; Chemello L; Fraiese A; Pasquali C; Alberti A
    Recenti Prog Med; 1986 Nov; 77(11):508-10. PubMed ID: 3027797
    [No Abstract]   [Full Text] [Related]  

  • 2. Virus receptors for polymerized human serum albumin and anti-receptor antibody in hepatitis B virus infection.
    Alberti A; Pontisso P; Chemello L; Schiavon E; Realdi G
    Prog Clin Biol Res; 1983; 143():327-36. PubMed ID: 6322199
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis B virus and polyalbumin receptors.
    Thung SN; Gerber MA
    Prog Liver Dis; 1986; 8():335-45. PubMed ID: 3012639
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibody to the hepatitis B virus receptor for polymerized albumin in acute infection and in hepatitis B vaccine recipients.
    Pontisso P; Schiavon E; Fraiese A; Pornaro E; Realdi G; Alberti A
    J Hepatol; 1986; 3(3):393-8. PubMed ID: 3031152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice.
    Renoux VM; Fleury MJ; Bousarghin L; Gaitan J; Sizaret PY; Touzé A; Coursaget P
    Vaccine; 2008 Dec; 26(51):6602-7. PubMed ID: 18835319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vaccines against the hepatitis B virus. The outstanding problems].
    Carreño V; Quiroga JA
    Rev Clin Esp; 1990 Oct; 187(5):247-8. PubMed ID: 2102538
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of candidate combination vaccine for hepatitis E and hepatitis B: a liposome encapsulation approach.
    Shrivastava S; Lole KS; Tripathy AS; Shaligram US; Arankalle VA
    Vaccine; 2009 Nov; 27(47):6582-8. PubMed ID: 19747579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [HBV and HIV infections. Serodiagnosis and vaccine. Yesterday, today, tomorrow?].
    Frei PC
    Rev Med Suisse Romande; 1989 Mar; 109(3):205-11. PubMed ID: 2524090
    [No Abstract]   [Full Text] [Related]  

  • 9. De novo infection in a renal transplant recipient caused by novel mutants of hepatitis B virus despite the presence of protective anti-hepatitis B surface antibody.
    Lu M; Lorentz T
    J Infect Dis; 2003 Apr; 187(8):1323-6. PubMed ID: 12696014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor IgM antibody response to hepatitis B core antigen in infants with hepatitis B virus infection.
    Margolis HS; Xu ZY; Nainan OV; Ou-Yang PY; Duan SC; Zhuang YL
    J Pediatr; 1989 Oct; 115(4):609-11. PubMed ID: 2529361
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis B vaccine.
    Drug Ther Bull; 1985 Jul; 23(13):49-51. PubMed ID: 3160568
    [No Abstract]   [Full Text] [Related]  

  • 12. A two dose combined hepatitis A and B vaccine in Chinese youngsters.
    Lee SD; Chan CY; Yu MI; Wang YJ; Chang FY; Lo KJ; Safary A
    J Med Virol; 1999 Sep; 59(1):1-4. PubMed ID: 10440800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of perinatal transmission of hepatitis B virus infection by HB-Ig and HB-vaccine].
    Ohryohji F; Umezu T; Ootsuka M; Kanda S
    Fukuoka Igaku Zasshi; 1984 Oct; 75(10):594-7. PubMed ID: 6240438
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis B vaccine with and without polymerised albumin receptors.
    Coursaget P; Barres JL; Chiron JP; Adamowicz P
    Lancet; 1985 May; 1(8438):1152-3. PubMed ID: 2860351
    [No Abstract]   [Full Text] [Related]  

  • 15. DNA vaccines expressing the duck hepatitis B virus surface proteins lead to reduced numbers of infected hepatocytes and protect ducks against the development of chronic infection in a virus dose-dependent manner.
    Miller DS; Kotlarski I; Jilbert AR
    Virology; 2006 Jul; 351(1):159-69. PubMed ID: 16624364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serologic epidemiology of hepatitis B viral infection and observation on the immunologic effect of hepatitis B vaccine].
    Ge QY
    Zhonghua Yu Fang Yi Xue Za Zhi; 1988 Mar; 22(2):92-4. PubMed ID: 3215090
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hepatitis B markers in health service personnel with reference to preventive vaccination].
    Stempień R; Małolepsza E; Jabłkowski M; Bielicka G; Górski T
    Pol Tyg Lek; 1988 Jul; 43(29):942-4. PubMed ID: 3237528
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaccination of ducks with a whole-cell vaccine expressing duck hepatitis B virus core antigen elicits antiviral immune responses that enable rapid resolution of de novo infection.
    Miller DS; Halpern M; Kotlarski I; Jilbert AR
    Virology; 2006 May; 348(2):297-308. PubMed ID: 16469347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
    Nayersina R; Fowler P; Guilhot S; Missale G; Cerny A; Schlicht HJ; Vitiello A; Chesnut R; Person JL; Redeker AG; Chisari FV
    J Immunol; 1993 May; 150(10):4659-71. PubMed ID: 7683326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune mechanisms in chronic hepatitis B and delta virus infections.
    McFarlane BM; Bridger CB; Smith HM; Antonov KA; Naoumov N; Williams R; McFarlane IG
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):615-21. PubMed ID: 8590155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.